Biotech Values

[DewDiligence]

More PPHM musings (#msg-98491664):

Any Big Pharma that acquires PPHM will double its market cap in the year following acquisition.

So, if the acquiring company has a market cap of, say, $150B, the market cap goes to $300B by merely adding PPHM. No problem!

Another pearl of wisdom (#msg-98493659):

…if you can charge $80k per dosing for PD-1, you can charge $120k for PD-1 +Bavi. Even if Bavi only makes them safer and doesn't add efficacy…it's a prudent business move to push the combo together from the onset using a synergistic MOA as the rationale.

Impeccable logic, LOL.